Clinical Trials Directory

Trials / Completed

CompletedNCT05499871

Effect of a Gait Retraining Intervention and a Minimalist Footwear Transition on Foot-ankle Strength, Running Economy and Injury in Endurance Runners.

Comparison Between Gait Retraining Intervention With a Transitioning Toward Minimalist Footwear on the Foot-ankle Strength, Running Economy and Injury Incidence in Endurance Runners: a One-year Follow up Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The main aim is to determine whether a gait retraining intervention will improve the strength of the foot-ankle muscle, the running economy and reduce the injury incidence in a one-year follow-up study. The secondary aim is to seek whether a minimal foot-ankle strength is necessary to reduce the risk to sustain to a running-related-injury to transit toward a forefoot strike pattern or toward a minimalist footwear for an endurance runner. Participants will be assessed at baseline, at 2 month follow-up, at 6 month follow-up and at 12 month follow-up. Assessment will be composed by questionnaires, a foot screening, maximal voluntary isometric strength of foot-ankle muscle with hand held dynamometer. Then, participants will run on a treadmill at self-paced and at 10 km/h with to measure their running economy and their footstrike pattern. In function of their distribution, participants will receive either nothing (control group) or minimalist footwear or a training to modify their footstrike pattern toward a more forefoot strike.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGait retraining interventionParticipants will receive a training to modify their footstrike pattern toward a more forefoot strike and increase their cadence by 7.5%.
DEVICETransition to minimalist footwear.Participants will receive a running minimalist footwear.

Timeline

Start date
2022-09-01
Primary completion
2022-09-12
Completion
2024-09-30
First posted
2022-08-12
Last updated
2025-05-16

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05499871. Inclusion in this directory is not an endorsement.